Carbapenem Market Size, Share & Trends Report

Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream Infections, Pneumonia), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-118-4
Number of Report Pages: 236
Format: PDF, Horizon Databook

Historical Range: 2018 - 2021
Forecast Period: 2023 - 2030
Industry: Healthcare

Market Segmentation

Global Carbapenem Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Meropenem
- Imipenem
- Ertapenem
- Others
Global Carbapenem Application Outlook (Revenue, USD Million, 2018 - 2030)
- Urinary Tract Infections
- Bloodstream Infections
- Intra-abdominal Infections
- Pneumonia
- Others
Global Carbapenem Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Carbapenem Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
    - Meropenem
    - Imipenem
    - Ertapenem
    - Others
  - North America Carbapenem Market, By Application, (USD Million, 2018 - 2030)
    - Urinary Tract Infections
    - Bloodstream Infections
    - Intra-abdominal Infections
    - Pneumonia
    - Others
  - North America Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - U.S.
    - U.S. Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - U.S. Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - U.S. Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Canada
    - Canada Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Canada Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Canada Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Europe
  - Europe Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
    - Meropenem
    - Imipenem
    - Ertapenem
    - Others
  - Europe Carbapenem Market, By Application, (USD Million, 2018 - 2030)
    - Urinary Tract Infections
    - Bloodstream Infections
    - Intra-abdominal Infections
    - Pneumonia
    - Others
  - Europe Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - UK
    - UK Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - UK Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - UK Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Germany
    - Germany Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Germany Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Germany Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - France
    - France Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - France Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - France Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Italy
    - Italy Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Italy Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Vaccines & Therapeutics
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Italy Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Spain
    - Spain Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Spain Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Spain Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Denmark
    - Denmark Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Denmark Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Denmark Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Sweden
    - Sweden Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Sweden Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Sweden Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Norway
    - Norway Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Norway Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Norway Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Asia Pacific
  - Asia Pacific Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
    - Meropenem
    - Imipenem
    - Ertapenem
    - Others
  - Asia Pacific Carbapenem Market, By Application, (USD Million, 2018 - 2030)
    - Urinary Tract Infections
    - Bloodstream Infections
    - Intra-abdominal Infections
    - Pneumonia
    - Others
  - Asia Pacific Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Japan
    - Japan Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Japan Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Japan Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - China
    - China Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - China Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - China Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - India
    - India Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - India Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - India Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Australia
    - Australia Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Australia Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Australia Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - South Korea
    - South Korea Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - South Korea Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - South Korea Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Thailand
    - Thailand Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Thailand Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Thailand Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Latin America
  - Latin America Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
    - Meropenem
    - Imipenem
    - Ertapenem
    - Others
  - Latin America Carbapenem Market, By Application, (USD Million, 2018 - 2030)
    - Urinary Tract Infections
    - Bloodstream Infections
    - Intra-abdominal Infections
    - Pneumonia
    - Acute Pelvic Infections
    - Others
  - Latin America Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Brazil
    - Brazil Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Brazil Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Brazil Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Mexico
    - Mexico Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Mexico Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Mexico Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Argentina
    - Argentina Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Argentina Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Argentina Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- MEA
  - MEA Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
    - Meropenem
    - Imipenem
    - Ertapenem
    - Others
  - MEA Carbapenem Market, By Application, (USD Million, 2018 - 2030)
    - Urinary Tract Infections
    - Bloodstream Infections
    - Intra-abdominal Infections
    - Pneumonia
    - Others
  - MEA Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - South Africa
    - South Africa Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - South Africa Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - South Africa Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Saudi Arabia
    - Saudi Arabia Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Saudi Arabia Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Saudi Arabia Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - UAE
    - UAE Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - UAE Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - UAE Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Kuwait
    - Kuwait Carbapenem Market, By Drug Class, (USD Million, 2018 - 2030)
      - Meropenem
      - Imipenem
      - Ertapenem
      - Others
    - Kuwait Carbapenem Market, By Application, (USD Million, 2018 - 2030)
      - Urinary Tract Infections
      - Bloodstream Infections
      - Intra-abdominal Infections
      - Pneumonia
      - Others
    - Kuwait Carbapenem Market, By Distribution Channel, (USD Million, 2018 - 2030)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.